BIOLOTEGACC — MERGEN RESEARCH SRL (Q2023771): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
| description / en | description / en | ||
Project in Italy | Project Q2023771 in Italy | ||
| description / it | description / it | ||
Progetto in Italia | Progetto Q2023771 in Italia | ||
Revision as of 06:02, 2 November 2020
Project Q2023771 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BIOLOTEGACC — MERGEN RESEARCH SRL |
Project Q2023771 in Italy |
Statements
467,854.95 Euro
0 references
623,806.6 Euro
0 references
75.0 percent
0 references
22 October 2017
0 references
16 October 2019
0 references
ISTITUTO NAZIONALE TUMORI IRCCS FONDAZIONE SENATORE G. PASCALE
0 references
MERIGEN RESEARCH SOCIETA' A RESPONSABILITA' LIMITATA
0 references
40°50'9.35"N, 14°14'55.61"E
0 references
BIOMOLTEACC - MERIGEN RESEARCH SRL - PROGETTI TRASFERIMENTO TECNOLOGICO E DI PRIMA INDUSTRIALIZZAZIONE PER LE IMPRESE INNOVATIVE AD ALTO POTENZIALE PER LA LOTTA ALLE PATOLOGIE ONCOLOGICHE (Italian)
0 references
BIOLEDACC — MERGEN RESEARCH SRL — TECHNOLOGY TRANSFER AND FIRST INDUSTRIALISATION PROJECTS FOR INNOVATIVE HIGH-POTENTIAL COMPANIES TO FIGHT CANCER DISEASES (English)
0 references
Identifiers
B63D18000220007
0 references